Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clyde W Yancy

Showing results (121-130 of 647) with videos related to

Pageof 65
Sort By:
Cardiology Clinics|August 2, 2011
Management of heart failure with renal artery ischemiaMadhav V Rao, Patrick Murray, Clyde W Yancy
The American Journal of Cardiology|May 3, 2011
Best clinical trials reported in 2010John B Garner, Paul A Grayburn, Clyde W Yancy
JAMA Cardiology|July 11, 2019
Impediments to Implementing Guideline-Directed Medical TherapiesGregg C Fonarow, Ann Marie Navar, Clyde W Yancy
Journal of Cardiac Failure|May 27, 2017
The ICD and Shared Decision Making: Nothing Is Ever EasyPaul W Goetz, Kathleen L Grady, Clyde W Yancy
JAMA Cardiology|August 14, 2020
The Use of Sacubitril/Valsartan for Hospitalized Heart Failure-Why Do We Care About Cost and Value?Clyde W Yancy, Adrian F Hernandez, Robert O Bonow
Archives of Internal Medicine|July 13, 2005
Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE RegistryGregg C Fonarow, Clyde W Yancy, J Thomas Heywood, et al.
JAMA Cardiology|February 4, 2026
The Cost-Effectiveness Evolution of Cardiovascular CareGregg C Fonarow, Ann Marie Navar, Clyde W Yancy
Circulation. Heart Failure|November 15, 2022
Heart Failure Data Challenge: Democratizing Data, Modernizing Methods, and Interpreting InequityLarry A Allen, Clyde W Yancy, Gregg C Fonarow
JAMA Cardiology|November 15, 2024
Interpreting Health Status Measures in Patients With Heart Failure-What CountsJames E Udelson, Clyde W Yancy, Gregg C Fonarow
Congestive Heart Failure (Greenwich, Conn.)|February 22, 2005
Novel therapies for heart failure: vasopressin and selective aldosterone antagonistsSandeep A Kamath, S Raja Laskar, Clyde W Yancy
Pageof 65

Showing results (121-130 of 647) with videos related to

Sort By:
Pageof 65
Cardiology Clinics|August 2, 2011
Management of heart failure with renal artery ischemiaMadhav V Rao, Patrick Murray, Clyde W Yancy
The American Journal of Cardiology|May 3, 2011
Best clinical trials reported in 2010John B Garner, Paul A Grayburn, Clyde W Yancy
JAMA Cardiology|July 11, 2019
Impediments to Implementing Guideline-Directed Medical TherapiesGregg C Fonarow, Ann Marie Navar, Clyde W Yancy
Journal of Cardiac Failure|May 27, 2017
The ICD and Shared Decision Making: Nothing Is Ever EasyPaul W Goetz, Kathleen L Grady, Clyde W Yancy
JAMA Cardiology|August 14, 2020
The Use of Sacubitril/Valsartan for Hospitalized Heart Failure-Why Do We Care About Cost and Value?Clyde W Yancy, Adrian F Hernandez, Robert O Bonow
Archives of Internal Medicine|July 13, 2005
Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE RegistryGregg C Fonarow, Clyde W Yancy, J Thomas Heywood, et al.
JAMA Cardiology|February 4, 2026
The Cost-Effectiveness Evolution of Cardiovascular CareGregg C Fonarow, Ann Marie Navar, Clyde W Yancy
Circulation. Heart Failure|November 15, 2022
Heart Failure Data Challenge: Democratizing Data, Modernizing Methods, and Interpreting InequityLarry A Allen, Clyde W Yancy, Gregg C Fonarow
JAMA Cardiology|November 15, 2024
Interpreting Health Status Measures in Patients With Heart Failure-What CountsJames E Udelson, Clyde W Yancy, Gregg C Fonarow
Congestive Heart Failure (Greenwich, Conn.)|February 22, 2005
Novel therapies for heart failure: vasopressin and selective aldosterone antagonistsSandeep A Kamath, S Raja Laskar, Clyde W Yancy
Pageof 65